1 – 10 of 142
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Association of Levonorgestrel-Releasing Intrauterine Device with Gynecologic and Breast Cancers: National Cohort Study in Sweden
2024) In American Journal of Obstetrics and Gynecology(
- Contribution to journal › Article
-
Mark
Antihypertensive drug targets and breast cancer risk : a two-sample Mendelian randomization study
2024) In European Journal of Epidemiology(
- Contribution to journal › Article
-
Mark
Revealing genes associated with cervical cancer in distinct immune cells : A comprehensive Mendelian randomization analysis
2024) In International Journal of Cancer(
- Contribution to journal › Article
- 2023
-
Mark
Identifying actionable druggable targets for breast cancer : Mendelian randomization and population-based analyses
(
- Contribution to journal › Article
-
Mark
Dipyridamole enhances the anti-cancer ability of aspirin against colorectal cancer by inducing apoptosis in an unfolded protein response-dependent manner
(
- Contribution to journal › Article
-
Mark
Re: Mark N. Brook, Holly Ní Raghallaigh, Koveela Govindasami, et al. Family History of Prostate Cancer and Survival Outcomes in the UK Genetic Prostate Cancer Study. Eur Urol 2023;83:257-66
(
- Contribution to journal › Letter
-
Mark
Mental health outcomes in parents of children with a cancer diagnosis in Sweden : A nationwide cohort study
(
- Contribution to journal › Article
-
Mark
Glucagon-like peptide-1 receptor agonists and diabetic retinopathy : nationwide cohort and Mendelian randomization studies
(
- Contribution to journal › Article
- 2022
-
Mark
Proguanil and atovaquone use is associated with lower colorectal cancer risk : a nationwide cohort study
(
- Contribution to journal › Article
-
Mark
Familial risk associated with lung cancer as a second primary malignancy in first-degree relatives
(
- Contribution to journal › Article